⌘K

Home/Filings/4/0001453687-26-000045

4//SEC Filing

Davis Blaine 4

Accession 0001453687-26-000045

CIK 0001453687other

View on SEC.gov Company Profile

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:19 PM ET

Size

4.8 KB

Accession

0001453687-26-000045

Insider Transaction Report

Form 4

Period: 2026-01-06

Cartesian Therapeutics, Inc.RNAC

Chief Financial Officer

Transactions

Sale
Common Stock
2026-01-06$6.82/sh−10,591$72,227→ 121,220 total

Footnotes (1)

[F1]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

Documents

1 file

4
wk-form4_1767907186.xmlPrimary
FORM 4

Issuer

Cartesian Therapeutics, Inc.

CIK 0001453687

Entity typeother

Related Parties

1

filerCIK 0001802188

Filing Metadata

Form type: 4
Filed: Jan 7, 7:00 PM ET
Accepted: Jan 8, 4:19 PM ET
Size: 4.8 KB

View on SEC.gov